Article

High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2

2021-12-07

Abstract excerpt

<h4>Objectives</h4> To assess the humoral and cellular responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in PLWHIV. <h4>Design</h4> Multicenter cohort study of PLWHIV, with a CD4 cell count <500/mm 3 and a viral load <50 copies/ml on stable antiretroviral therapy for at least 3 months. <h4>Methods</h4> Anti-SARS-CoV-2 Receptor Binding Domain IgG antibodies (anti-RBD IgG) were quantified and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1d283e67-4828-52a9-8cba-cd1b3eaf9812
DOI: 10.1101/2021.12.07.21267395

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2DOI 10.1101/2021.12.07.21267395Read

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsSemantic proximity Read

Age Dependent Reduction of Neutralization Capacities Against Delta Variant Five Months Post-Vaccination (BNT162b2)Semantic proximity Read

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike VariantsSemantic proximity Read

Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunitySemantic proximity Read

Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised PatientsSemantic proximity Read

Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prospective single center studySemantic proximity Read

Neutralization-activity of Sera/IgG Obtained from Fully BNT162b2- Vaccinated Individuals Against 10 Clinical SARS-CoV-2 isolates Including Various VOCs (Alpha/Beta/Gamma/Delta) and VUM (Kappa)Semantic proximity Read

Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against OmicronSemantic proximity Read

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccineSemantic proximity Read

Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older PeopleSemantic proximity Read

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccineSemantic proximity Read

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS StudySemantic proximity Read